Intra-operative Loop Diuretics to Improve Same-day Discharge Rates After HoLEP

Recruiting now · Phase 3

Conditions studied: BPH With Urinary Obstruction, BPH, Hematuria, Same Day Discharge

In brief

Holmium Laser Enucleation of the Prostate (HoLEP) is a size-independent treatment option for benign prostatic hypertrophy (BPH) as recommended by the American Urological Association (AUA) Guidelines. Loop diuretics (furosemide) have been given historically during the morcellation portion of HoLEP to promote urine production in the post-operative setting and to minimize the impact of fluid absorption during long periods of morcellation. The intra-operative use of 20mg IV furosemide in perioperative HoLEP pathways has been propagated with the dissemination of HoLEP across North America without evidence to support its routine administration. With increasing surgical efficiency from improvements in laser and morcellator technology, the role of intra-operative furosemide is unknown. This study is designed to assess if there is a significant difference in same day discharge rates after Holmium Laser Enucleation of the Prostate (HoLEP) with and without IV furosemide. .

Key facts

Study ID
NCT05620784
Run by
Northwestern University
People needed
138
Starts
2023-03-01
Expected to finish
2024-08-01
Last updated by the study team
2023-09-13

Who can join

Age: 18 and older, up to 89. Sex: male. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.